Spine Surgery Devices Market Size, Share, Trends & Forecast 2021

According to the new market research "Spine Surgery Devices Market by Technology (Fusion, Fixation, VCF, Decompression, Motion Preservation), Product (Thoracic, Lumbar, Cervical, Interbody, Kyphoplasty, Artificial Discs, MIS, Biologics, Stimulators) - Global Forecast to 2021", The market is expected to reach USD 17.27 Billion by 2021, growing at a CAGR of 5.3% from 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

A number of factors such as rising incidence and prevalence of spinal disorders; development of technologically advanced, safer, and cost-effective spinal devices; global rise in the old age and obese population; and rising demand for minimally invasive spine surgery are fueling the growth of the Spine Surgery Devices Market. On the other hand, factors such as stringent regulatory guidelines for the approval of new medical devices, high procedural costs, and lack of adequate reimbursements in developing countries are restricting the growth of the global Spine Surgery Devices Market.

Browse and in-depth TOC on "Spine Surgery Devices Market "
82 – Tables
51 - Figures 
211 - Pages 

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/spine-surgery-devices-market-712.html 

The Spine Surgery Devices Market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, spinal decompression and motion preservation/non-fusion technologies. On the basis of products, the global Spine Surgery Devices Market is divided into seven major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, spinal decompression devices, and spine bone stimulators. Based on the type of surgery, the global Spine Surgery Devices Market is divided into two segments, namely, open surgery and minimally invasive surgery.

As of 2016, North America is estimated to hold the largest share of the global Spine Surgery Devices Market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness about the newly developed spine treatment techniques and devices are propelling the growth of the Spine Surgery Devices Market in the Asia-Pacific region.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712

However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness about spinal disorders and treatment options restricts the market growth in this region.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=712   
Medtronic, plc (Ireland), DePuy Synthes (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V. (Netherlands), K2M Group Holdings, Inc. (U.S.), and RTI Surgical, Inc.  (U.S.) are the key players operating in the global Spine Surgery Devices Market.


Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Ambulatory EHR Market Size, Share, Trends & Forecast 2021

The report “Ambulatory EHR Market By Delivery Mode (Cloud-based, On-premise), Application (Practice Management, Patient Management, Referral Management, Health Analytics), Practice Size (Large, Small-to-medium, Solo), End User-Global Forecast to 2021”, report provides a detailed overview of the major drivers, restraints, opportunities, and threats impacting the ambulatory EHR market along with the estimates and forecasts of the revenue and market share analysis.

The global ambulatory EHR market is expected to reach USD 5.20 billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021).

Growth in this market can be attributed to various factors such as government support for the adoption of HCIT, growing usage of EHR solutions, and the need to curtail healthcare costs. On the other hand, market growth is limited to a certain extent due to factors such as heavy infrastructure investments and the high cost of deployment.

The market is segmented on the basis of delivery mode, application, practice size, end user, and region. On the basis of delivery mode, the market is segmented into cloud-based solutions and on-premise solutions. The cloud-based solutions segment accounted for the largest share of the market in 2016. Cloud-based ambulatory EHR solutions are based on the SaaS (software-as-a-service) model, which utilizes a group of servers to spread data processing tasks across healthcare organizations. In addition, cloud services help curtail costs incurred in the purchase of hardware and the licensing of software.

Download Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=235617627  

On the basis of application, the ambulatory EHR market is segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics. The practice management segment commanded the largest share of the global ambulatory EHR market in 2016. This growth can be attributed to the increasing adoption rate among healthcare providers, as they are shifting from pay-per-procedure billing to paying for ‘value’—that is, incentives for providing better care efficiently.

Based on practice size, the ambulatory EHR market is segmented into large, small-to-medium, and solo practices. The large practices segment commanded the largest share of the global ambulatory EHR market in 2016. The small-to-medium-sized practices segment is estimated to register the highest growth rate primarily due to the funding provided by the regional exchange centers (REC) to support the adoption of EHR among these users.

Download Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235617627 

Based on end user, the ambulatory EHR market is segmented into hospital-owned ambulatory centers and independent centers. The hospital-owned ambulatory centers segment commanded the largest share of the global ambulatory EHR market in 2016. The high growth in this segment is attributed to expansion initiatives by hospitals (allowing them to establish ambulatory care centers and necessitating the adoption of solutions for streamlining workflow). In addition, the benefits of EHR solutions, such as operational savings and enabling patient involvement in medical decisions, have also driven their adoption among these end users.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America commanded the largest share of the global ambulatory EHR market, followed by Europe. Asia-Pacific is projected to register the highest CAGR during the forecast period. Factors such as Japan’s favorable outlook for HCIT, investments and reforms to modernize China’s healthcare infrastructure, digital healthcare scenario in India, and the implementation of e-Health in Australia are likely to boost market growth in the region.

The major market players in the ambulatory EHR market include Cerner Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Epic Systems Corporation (U.S.), eClinicalWorks (U.S.), athenahealth, Inc. (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Practice Fusion, Inc. (U.S.), Amazing Charts, LLC (U.S.), eMDs, Inc. (U.S.), GE Healthcare (U.S.), and Greenway Health, LLC (U.S.)

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441

newsletter@marketsandmarkets.com 

Veterinary reference laboratory market worth $2.8 billion by 2021

The veterinary reference laboratory market is expected to reach USD 2.8 billion by 2021 from an estimated USD 1.7 billion in 2016, at a CAGR of 9.8%. The rising animal health expenditure, growing demand for pet insurance, increasing incidences of zoonotic diseases, and growth in the number of veterinarians and their rise in income levels in developed countries are the significant growth drivers of the veterinary reference laboratory market.

Browse 202 market data Tables and 36 Figures spread through 218 Pages and in-depth TOC on "Veterinary reference laboratory market”
https://www.marketsandmarkets.com/Market-Reports/veterinary-reference-laboratory-market-256972714.html

“The clinical chemistry segment is expected to dominate the veterinary reference laboratory market during the forecast period.”

On the basis of technology, the veterinary reference laboratory market is segmented in clinical chemistry, hematology, immunodiagnostics, and molecular duiagnostics. The clinical chemistry segment is expected to account for the largest share of the veterinary reference laboratory market in 2015. The large share of this segment can be attributed to its wide applications in small veterinary clinics and hospitals as well as in reference laboratories. Clinical chemistry is one of the most important areas in clinical laboratory analysis and this field has advanced significantly in recent years. In the veterinary industry, clinical chemistry tests are used to diagnose diseases, screen disease progression, and observe responses of patients to therapy.

Ask for discount: https://www.marketsandmarkets.com/discountreports.asp?id=256972714   

“Clinical pathology to hold the largest market share between 2016 and 2021.”

Based on applications, the market has been classified into clinical pathology, bacteriology, parasitology, virology, productivity testing, pregnancy testing, and toxicology. In 2015, clinical pathology accounted for the largest market share owing to the high number of diagnostic tests fall under this application. In clinical pathology, diagnosis of diseases is carried out by using samples such as blood and other bodily fluids, tissues, and microscopic evaluation of individual cells. Clinical pathology encompasses hematology, clinical chemistry, cytopathology, endocrinology, urinalysis, coagulation, immunohematology, and general pathology. In case of chronic disease conditions, veterinarians recommend routine blood check-ups where clinical pathologists work along with veterinarians to evaluate the cause of the disease.

“The companion animals segment to account for the largest market share in 2015.”

Based on animal type, the veterinary reference laboratories market is categorized into companion animals and food-producing animals. In 2015, the companion animals segment accounted for the largest share of around 68.7% of the global veterinary reference laboratories market. The large share of this segment is mainly due to the rising demand for pet health insurance, increase in the animal healthcare expenditure, and greater concerns about zoonotic diseases.

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=256972714

“North America to dominate the market in 2015.”

The global veterinary reference laboratory market has been segmented into North America, Europe, Asia Pacific, and Rest of the World (Latin America, and the Middle East & Africa). In 2015, North America accounted for the largest share of the veterinary reference laboratory market. The rise in the consumption of animal-derived food products, increasing demand for companion animal healthcare products, rising awareness about zoonotic diseases, and rising demand for innovative diagnostic testing services by veterinarians, pet owners, and food-producing animal producers in this region are some of the key factors driving the growth of the veterinary reference laboratory market in North America.

The prominent players in the global veterinary reference laboratory market are IDEXX Laboratories, Inc. (US), VCA, Inc. (Mars, Incorporated) (US), GD Animal Health (Netherlands), National Veterinary Services Laboratory (US), Animal and Plant Health Agency (DEFRA APHA Scientific) (UK), Animal Health Diagnostic Center (Cornell University) (US), Greencross Limited (Australia), Gribbles Veterinary Pathology (Australia), Phoenix Central Laboratory for Veterinarians, Inc. (US), Zoetis, Inc. (US), Neogen Corporation (US), ProtaTek Internationals Inc. (US), Wisconsin Veterinary Diagnostic Laboratory (US), and Washington State University Veterinary Clinical Pathology Laboratory (US).

Request for special pricing on bundle reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=256972714

Study Coverage

This report describes and studies the global veterinary reference laboratory market on the basis of technology, application, animal type, and region. It provides detailed information regarding the major factors influencing the growth of this market. The report includes in-depth competitive analysis of the prominent players in this market along with their company profiles, product portfolios, recent developments, and key business strategies.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

newsletter@marketsandmarkets.com